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Abstract
The emergence of antibiotic-resistant bacterial strains underscores the importance of identifying new drug targets and
developing new antimicrobial compounds. Lysine and meso-diaminopimelic acid are essential for protein production and
bacterial peptidoglycan cell wall remodeling and are synthesized in bacteria by enzymes encoded within dap operon.
Therefore dap enzymes may serve as excellent targets for developing a new class of antimicrobial agents. The dapE-
encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) converts N-succinyl-L,L-diaminopimelic acid to L,L-
diaminopimelic acid and succinate. The enzyme is composed of catalytic and dimerization domains, and belongs to the M20
peptidase family. To understand the specific role of each domain of the enzyme we engineered dimerization domain
deletion mutants of DapEs from Haemophilus influenzae and Vibrio cholerae, and characterized these proteins structurally
and biochemically. No activity was observed for all deletion mutants. Structural comparisons of wild-type, inactive
monomeric DapE enzymes with other M20 peptidases suggest that the dimerization domain is essential for DapE enzymatic
activity. Structural analysis and molecular dynamics simulations indicate that removal of the dimerization domain increased
the flexibility of a conserved active site loop that may provide critical interactions with the substrate.
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Introduction
Emerging antibiotic resistance has been recognized as a world-
wide health issue since the introduction of penicillin more than 80
years ago [1,2]. Most importantly, the rapid emergence of resistant
bacteria makes today’s antibiotics more and more ineffective,
consequently increasing the need for a novel class of antibacterial
agents [3]. Currently available antibiotics target only a limited
number of microbial pathways and employ two major strategies: (i)
inhibition of cell wall remodeling and (ii) inhibition of protein
synthesis. As a result, only two new classes of antibacterial drugs
have reached the market since 1962. The Center for Disease
Control and Prevention (CDC) recently reported the emergence of
several strains of Staphylococcus aureus that are resistant to even the
most powerful antibiotic of last resort, vancomycin. These cases
emphasize the fact that no drug can prevent a simple staph
infection from becoming deadly [4]. According to the Infectious
Diseases Society of America, a minimum of ten new systemic
antibacterial drugs need to enter the market by the year 2020 in
order to maintain proper control of infectious diseases. Therefore,
development of new classes of inhibitors that target essential
metabolic pathways and unique enzymes is critical in order to
maintain control of infectious diseases [5,6].
The lysine biosynthetic pathway offers several enzymes that
could serve as potential drug targets [7,8]. Two products of this
pathway, lysine and meso-diaminopimelate (mDAP), are essential
for protein and peptidoglycan cell wall synthesis in Gram-negative
and most Gram-positive bacteria. Many bacteria, plants and algae
synthesize lysine and meso-diaminopimelic acid (mDAP) from
succinic acid [9,10,11]. In contrast, lysine is not synthesized in
humans but it is an essential amino acid, therefore it must be
ingested. It has been shown that deletion of the dapE gene in the
mDAP/lysine biosynthetic pathway that encodes the N-succinyl-
L,L-diaminopimelic acid desuccinylase (DapE) is lethal in Helico-
bacter pylori and Mycobacterium smegmatis [12,13]. DapE hydrolyzes
N-succinyl-L,L-diaminopimelic acid to L,L-diaminopimelic acid
and succinate, is part of a biosynthetic pathway that is the major
source of lysine in bacteria, and is essential for cell growth and
proliferation. Since there are no similar biosynthetic pathways in
mammals, inhibitors that target DapEs are hypothesized to exhibit
selective toxicity against bacteria and have little or no effect on
humans [9,14]. DapE coding genes have been identified in all
pathogenic Gram-negative bacteria, and the enzyme has been
purified and characterized from several sources [8]. Of particular
interest are DapEs from the ‘‘ESKAPE’’ pathogens (Enterococcus
faecium, Staphylococcus aureus, Klebsiella pneumonia, Acinetobacter
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baumanii, Pseudomonas aeruginosa and Enterobacter species), which
account for more than 60% of the antibiotic resistant hospital
acquired infections in the United States (13–18). Alignment of the
DapE gene from Haemophilus influenzae (HiDapE) with the gene
sequences of DapEs from ‘‘ESKAPE’’ pathogens reveals at least
49% identity [15].
All the DapE enzymes characterized to date belong to the M20
family of dinuclear Zn(II)-dependent metalloproteases. Structural
studies of M20 metalloproteases showed that these enzymes exist
as dimers comprised of catalytic and dimerization domains or
monomers having a single catalytic domain (16). Structural studies
on HiDapE revealed that the enzyme belongs to the former group
composed of a larger thioredoxin-like 3-layer (aba) sandwich
domain that carries out catalysis and a smaller ferrodoxin-like
domain providing the dimer interface [16]. The core of the
catalytic domain consists of an eight-stranded twisted b-sheet that
is sandwiched between seven a-helices and houses the active site.
The active site is constituted by residues from five loops, contains
two zinc ions, and is exposed to the solvent.
The architecture of the active site of HiDapE and the core of the
catalytic domain are strikingly similar to the aminopeptidase from
Aeromonas proteolytica (AAP) and the carboxypeptidase from
Pseudomonas sp strain-RS-16 (CPG2) [17,18], even though they
catalyze markedly different hydrolytic reactions. One explanation
for this similarity is the highly flexible design of their active sites,
which are constructed by five loops. This design preserves the
dinuclear catalytic core and at the same time allows for evolution
of specificity for new substrates without the need for major
modifications to the overall structure. The flexibility of the active
site is especially relevant from the perspective of understanding
substrate recognition and binding, which is directly related to
inhibitor design. In order to examine the role of the catalytic
domain of DapE enzymes and the role of the active site loops, we
have engineered the HiDapE and the DapE from Vibrio cholerae
(VcDapE) by deleting their dimerization domains. This truncation
leads to protein constructs that have only the catalytic domain, are
monomeric in solution, and closely resemble AAP. Kinetic
characterization of the truncated DapEs (VcDapET and HiDapET)
shows that the catalytic domain alone is completely inactive. X-ray
crystallographic data and molecular dynamic simulations along
with site-directed mutagenesis studies provide insight into the role
of the dimerization domain and underlying importance of the
active site loops in catalysis.
Materials and Methods
Gene cloning and protein expression
The coding genes of full-length VcDapE and HiDapE were
cloned into vector pMCSG7 and amplified by PCR from V.
cholerae O1 biovar El Tor str. N16961 (ATCC) and from H.
influenzae strain (ATCC), respectively, with KOD DNA polymerase
using conditions and reagents according to the standard protocol
described previously [19]. The truncated version of HiDapET
(residues 181–294 deleted) and VcDapET (residues 181–295
deleted) were designed based on the full-length HiDapE structure
and were cloned using the same procedure. These deletion
proteins were reengineered in such a way that the C-terminal
domain was truncated at the connector region between the
dimerization and the catalytic domains and replaced with a GG
linker. The deletion of the region coding for the dimerization
domain was achieved via PCR of pMCSG7-VcDapE and
pMCSG7-HiDapE according to the previously described protocol
[20]. The following primers were used: VcDapET 181–295;
59TGGCGGTGGCTTCCTGACCGATACGGGCGA39 and
59GGAAGCCACCGCCACGACGGCCATTTTTCACC39, Hi-
DapET 181–294; 59CGGCGG TGGCTTTTTAACAAAAC-
CAGGTAAATTATTAGATTCGATAACC39 and
59AAAAAGCCACC GCCGCGGCGACCATTTTTGAC39.
This process generated expression clones of fusion proteins that
have an N-terminal His6-tag, a TEV protease recognition site
(ENLYFQQS), followed by the DapE catalytic domain. All
proteins were expressed in an E. coli BL21(DE3)-derivative that
harbors the pMAGIC plasmid encoding one rare E. coli Arg tRNA
(covering codons AGG/AGA). The transformed BL21(DE3) cells
were grown at 37uC in Luria-Bertani medium and protein
expression was induced with 1 mM isopropyl-b-d-thiogalactoside
(IPTG). The cells were then incubated and shaken vigorously at
18uC overnight. The harvested cells were re-suspended in lysis
buffer (500 mM NaCl, 5% (v/v) glycerol, 50 mM HEPES,
pH 8.0, 10 mM imidazole, 10 mM 2-mercaptoethanol) and stored
at 280uC.
Purification of VcDapE, VcDapET and HiDapET
The VcDapE, VcDapET and HiDapET proteins were purified
according to the standard protocol for Ni-NTA affinity chroma-
tography, as described previously [19]. The His6-tag was removed
by treating each enzyme with His6-tagged TEV protease for 16 h
at 4uC in 50 mM HEPES, pH 8.0. Cleaved protein was separated
from TEV using Ni-NTA affinity chromatography. After Ni-NTA
column chromatography, VcDapET and HiDapET were further
purified by size-exclusion chromatography on a HiLoad 16/600
Superdex 200 Prep Grade (GE Healthcare) using standard
crystallization buffer (250 mM NaCl, 20 mM HEPES pH 8.0,
and 1 mM TCEP) and concentrated to 25 mg/ml. The full-length
VcDapE protein was purified according to the same procedure
however the size-exclusion chromatography step revealed forma-
tion of ‘‘soluble aggregates’’. Therefore, the buffer conditions were
altered such that the salt concentration was increased to 800 mM
NaCl and glycerol (10%) was added, allowing for purification of
small quantities of soluble protein.
Kinetic characterization of VcDapE, VcDapET, and HiDapET
Recombinant WT-VcDapE, VcDapET, and HiDapET were
characterized biochemically by monitoring amide bond cleavage
of L,L-SDAP at 225 nm (e= 698 M21 cm21). The assay was
performed in triplicate in 50 mM phosphate buffer, pH 7.5, in the
presence of two equivalents of Zn(II). Enzyme activities were
expressed as units/mg where one unit is defined as the amount of
enzyme that releases 1 mmol of L,L-SDAP at 25uC in 1 min. Km
and kcat values were obtained by fitting initial rates data to the
Michaelis-Menten equation using Origin software [21,22,23].
Catalytic activities were determined with an error of 610%.
Protein crystallization
The sitting-drop vapor-diffusion method was used to obtain
crystals of VcDapET and HiDapET at 16uC using a Mosquito
liquid handling robot with 96 well plates. Crystals of both the apo-
and dinuclear Zn(II)-loaded forms of VcDapET were obtained
using 400 nl of a precipitant solution (20% (v/v) 1,4-butanediol,
0.1 M sodium acetate pH 4.5) and 400 nl a 19 mg/ml solution of
VcDapET in crystallization buffer, within 14 days. In order to grow
the crystals of dinuclear Zn(II)-loaded forms of VcDapET, a 1 mM
ZnCl2 solution was added to the protein solution.
Crystals of HiDapET were obtained using 400 nl of a
precipitant solution (0.2 M ammonium acetate, 0.1 M BIS-TRIS
pH 5.5, 25% (w/v) polyethylene glycol 3350) and 400 nl of a
15 mg/ml solution of HiDapET within two weeks. The asymmet-
ric unit contains two monomeric molecules of the HiDapET. For
The Role of the Active Site Loop in DapE
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cryo-protection, all crystals were transferred to the mother liquid
containing a 25% mixture of glycerol and ethylene glycol.
Data collection and structure determination
Prior to data collection, the X-ray florescence spectrum was
recorded for VcDapET, HiDapET and apo-VcDapET crystals,
which identified the presence of Zn ions in the protein crystals of
VcDapET and HiDapET. Data collection was carried out on the
19-ID beam line of the Structural Biology Center at the Advanced
Photon Source according to procedures described previously [16].
Data were collected at a wavelength of 0.98 A˚ from the single
crystals and were processed using HKL3000. Crystallographic
parameters are summarized in Table 1. Initially, data for
VcDapET and HiDapET were processed, scaled and the structures
refined in the space group P3212. Even though these models
refined with low R-factors (Rcryst/Rfree =,16/18%), spurious
density features were observed in the electron density maps. Re-
examination of these data suggested a twinning test be performed
using Xtriage in Phenix [24], which indicated twinning. The
twinning operator is parallel to the two-fold axis making the space
group pseudo P3212. Therefore, data were rescaled in the space
group P32. The structures of VcDapE
T and HiDapET were
determined by molecular replacement using the catalytic domain
of HiDapE (PDB ID 3IC1) as a search model [16]. Molecular
replacement searches were completed using MOLREP of the
CCP4 suite [25,26]. The initial models were rebuilt manually and
refined using programs REFMAC 5.5 [27] and Phenix [24]. The
final models were refined against all reflections except for 5%
randomly selected reflections, which were used for monitoring
Rfree. The final rounds of refinement were carried out using TLS
refinement with 5 TLS groups. The final refinement statistics for
all structures are presented in Table 1. Analysis and validation of
the structures were performed with the aid of MOLPROBITY
and COOT validation tools. Figures were prepared using Pymol.
Protein Data Bank accession code
The atomic coordinates and structure factor file for the
structure of the catalytic domain of apo-VcDapET, ZnZn-
VcDapET and ZnZn-HiDapET have been deposited in the RCSB
Protein Bank with accession code 4ONW, 4OP4 and 4H2K,
respectively.
Determination of Molecular Weight of VcDapE, VcDapET
and HiDapET
The molecular weight (MW) of the HiDapE, HiDapET and
VcDapET proteins in solution were determined using size-
exclusion chromatography (SEC) on a HiLoad 16/600 Superdex
200 Prep Grade column (GE Healthcare) in the crystallization
buffer at 5 mg/ml concentrations. The column was calibrated
with aprotinin (6.5 kDa), ribonuclease A (13.7 kDa), carbonic
anhydrase (29 kDa) ovalbumin (43 kDa), conalbumin (75 kDa),
aldolase (158 kDa), ferritin (440 kDa), and thyroglobulin
(669 kDa) as standards. A calibration curve of Kav vs. log MW
was prepared using the equation Kav =Ve2Vo/Vt2Vo, where
Ve = elution volume for the protein, Vo = column void volume, and
Vt = total bed volume (Supplementary Materials Figure S1A in File
S1).
Dynamic light scattering (DLS) assessments
DLS analyses were performed using the DynaPro-801 molec-
ular sizing instrument (Protein Solutions) at 21uC. Aliquots of
protein samples collected from the SEC column were concentrated
to a final concentration of 2.0 mg/ml in the crystallization buffer.
The solutions were filtered with Ultrafree-MC microcentrifuge
filters (0.22 mm, Millipore) and centrifuged at 20,000 g for 10 min
at 4uC and before measurements were taken. Hydrodynamic radii
(RH), degree of sample polydispersity and MWs were calculated
using the manufacturer’s software version 5.25.44.
Molecular modeling and dynamics simulations
The structure of the catalytic domain of VcDapET is well
ordered and excellent electron density is observed for protein
main-chain, side-chains, metal, phosphate ions, and water
molecules. Using the VMD molecular graphics program [28],
the protein model with its hydrogen atoms was created and placed
in a water-box containing 7826 TIP3 water molecules [29], 13
sodium, and 2 chloride ions to neutralize the charge and provide
counter ions. The charges on the histidine residues were
determined by inspection of their local environments. The energy
of this initial structure was minimized with 3,000 steps of
conjugated gradient minimization using the CHARMM27 force
field [30] and the NAMD molecular dynamics (MD) program
[31]. The structure was relaxed by gradually heating it from 10 to
310 K in steps of 10 K with 1,000 steps of molecular dynamics at
each temperature. Periodic boundary conditions were used. The
cutoffs for non-bonding (van der Waals and electrostatic)
interactions were 12 A˚. The switch distance was 10 and 1.0 A˚
using a 1–4 scaling factor. The time step was 2 fs. These
conditions were used for all of the molecular dynamics simulations.
After 10,000 steps of pressure and temperature equilibration using
a Langevin piston, the system was subjected to 30,000 steps of
molecular dynamics. This process constitutes equilibration of the
structure. The structures for HiDapET and HiDapE were also
equilibrated in the same manner. Since these X-ray structure
models had a few loops missing due to the poor electron density
maps, the missing regions were modeled using the modeling tools
found in Swiss PDB Viewer [32]. The complete VcDapE structure
was produced through homology modeling, using HiDapE as a
template through the automated mode of the Swiss Model service
[33]. The two chains of VcDapE were produced separately from
each other, combined using VMD, and equilibrated in the manner
previously described. The X-ray structure for AAP (PDB ID
1RTQ) [18] was used as a standard for comparison as AAP and
dinuclear Zn(II)-loaded VcDapET and HiDapET are characterized
by similar active sites and sequence lengths.
For each of these five structures, 5 ns of simulation data were
accumulated. The rmsd per residue values were calculated for MD
production runs of the four structures using the VMD molecular
graphics program [28]. These calculations were used to determine
structural changes between each of the five structures. MOLMOL
plots [34] were also generated for each structure to give a visual
depiction of the structural changes, especially for areas of large
movement. For these diagrams 171 equally spaced snapshots over
a 5 ns simulation were used for each of the five proteins. Three of
the simulations (ZnZn(VcDapET), HiDapET and HiDapE) were
run for 10 ns, but there were no significant differences in the
flexibilities of these when the second 5 ns simulations were
compared with the first 5 ns.
Loop V Site Directed Mutagenesis
The site-directed mutants T325A, T325S and T325C of WT-
HiDapE were prepared using the Quick Change Site-Directed
Mutagenesis Kit (Stratagene) following the procedure outlined by
Stratagene using the following primers, T325A: 59-
ACAGGTGGCGGCGCGTCAGACGGTC-39, 59-
GACCGTCTGACGCGCCGCCACCTGT-39, T325S: 59-
ACAGGTGGCGGCTCGTCAGACGGTC-39, 59-
The Role of the Active Site Loop in DapE
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GACCGTCTGACGAGCCGCCACCTGT-39, T325C: 59-
GCTGAAACAGGTGGCGGCTGCTCAGACGGTCGTTT-
TATT-39, 59-AATAAAACGACCGTCTGAGCAGCCGC-
CACCTGTTTCAGC-39. Polymerase Chain Reaction (PCR)
was performed using 70 ng of a dsDNA template. PCR was
performed at 95uC for 30 seconds followed by 16 cycles of (95uC
for 30 seconds, 55uC for 1 minute, 68uC for 5 minutes) and final
extension at 68uC for 6 minutes. Reaction products were
transformed into BL21(DE3)/magic E. coli competent cells
(Invitrogen) and grown on Luria-Bertani agarose plates containing
ampicillin (100 mg mL21) and kanamycin (25 mg mL21). A single
colony of each mutant was grown in 5 mL Luria-Bertani medium
containing ampicillin (100 mg mL21) and kanamycin
(25 mg mL21). Plasmids were isolated using the QIAprep-Spin
Miniprep Kit (QIAGEN). The plasmid DNA was sent to the DNA
sequencing facility (University of Chicago Cancer Research
Center DNA Sequencing Facility, Chicago IL) to confirm the
mutations. Glycerol stocks were prepared and stored at 280uC
until further needed. Purification of HiDapE T325A, T325C and
T325S mutant enzymes and kinetic characterization was con-
ducted as described above. Circular dichroism (CD) spectra were
recorded on an Olis DSM-20 CD spectrophotometer at 25uC in
50 mM HEPES, 300 mM NaCl at pH 7.5 (Supplementary
Materials Figure S1B in File S1).
Table 1. Data and Refinement Statistics.
Data collection statistics VcDapET-apo VcDapET-ZnZn HiDapET-ZnZn
Space group P32 P32 P21
Unit cell (A˚) a = 49.6 a = 49.9 a = 61.7
b = 49.6 b = 49.9 b = 44.7
c = 232.6 c = 231.8 c = 92.5
b= 92.9u
Resolution (A˚) 37.6-1.65 40-1.65 30-1.84
Wavelength (A˚) 0.98 A˚ 0.98 0.98
Number of observed reflections 523779 299329 99336
Number of unique reflections 77006 70716 42453
Redundancyb 6.8 (3.8) 4.2(1.8) 2.3(2.2)
Rmerge
a,b (%) 5.9 (50.1) 5.1 (26.0) 9.2 (55.7)
Rrim
a,b (%) 6.4 (56.7) 5.8 (35.5) 10.5(82.6)
Rpim
a,b (%) 2.4 (25.8) 2.6 (23.1) 6.5(51.0)
Completenessb (%) 99.6 (93.8) 91.3 (49.2) 96.5 (97.8)
I/s 40 (2.3) 23.2 (2.1) 9.5 (2.1)
Phasing
phasing method MR MR MR
Refinement statistics
Rcryst (%) 13.81 14.32 19.7
Rfree (%) 17.13 16.59 24.9
protein residues 532 513 505
zinc ion/acetate/butanediol/glycerol/ethanediol/ -/1/6/2/4 2/-/6/3/3 4/-/-/-/-
solvent 541 541 284
Rmsd from target values
bond lengths (A˚) 0.020 0.020 0.021
bond angles (deg) 2.11 1.43 2.03
Average B factors (A˚2)
protein 14.78 14.77 27.7
Zn - 13.93 26.1
H2O 28.10 24.19 38.7
PDB ID 4ONW 4OP4 4H2K
Ramachandran (%)c M.F./A.A. 97.5/2.5 97.3/2.7 96.8/3.0
aRmerge =ShklSi|Ii(hkl)2ÆIhklæ|/ShklSiIi(hkl), where Ii(hkl) is the ith observation of reflection hkl, and ÆIhklæ is the weighted average intensity for all observations i of reflection
hkl.
Rrim~Shkl N
.
N{1ð Þ1=2
 
Si Iij (hkl){Ihkl =Shklj Si Ii hklð Þ , and Rpim~Shkl 1
.
N{1ð Þ1=2
 
Si Ii(hkl){Ihkl =ShklSi Ii hklð Þ
 .
bNumbers in parentheses are values for the highest-resolution bin.
cAs defined by MOLPROBITY (M.F. –the most favored/A.A additionally allowed).
doi:10.1371/journal.pone.0093593.t001
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Results
Kinetic characterization of wild-type and truncated DapE
Kinetic data were obtained for recombinant VcDapE, HiDapE,
VcDapET, and HiDapET by monitoring amide bond cleavage of
L,L-SDAP at 225 nm. The kcat value obtained for WT-VcDapE
was 80610 s21, with a corresponding Km value of 1.260.2 mM
while the kcat value obtained for HiDapE was 114610 s
21, with a
Km value of 0.860.1 mM, which is in good agreement with
previous studies [23] (Surprisingly, no detectable activity was
observed for HiDapET or VcDapET under the standard assay
conditions.
Structure of the catalytic domain of HiDapET
Deletion of the dimerization domain led to a monomeric
structure for HiDapET. The monomeric nature of HiDapET in
solution was corroborated by size exclusion chromatography
(SEC) and dynamic light scattering (DLS). The SEC analysis
confirmed a weight (MW) of 28.4 kDa (the theoretical mass of a
monomer is 28.9 kDa, while the wild-type dimer’s theoretical mass
is 82.6 kDa) (Supplementary Material Figure S1A in File S1). DLS
experiment revealed a monomodal solution containing particles
with an average hydrodynamic radius of the 2.52 nm and an
estimated average MW of 28.7 kDa (Table 2). The structure of
HiDapET was determined and refined at 1.84 A˚ resolution and the
final model shows two independent monomers in the asymmetric
unit. The structure of the catalytic domain is virtually identical to
the catalytic domain of full-length HiDapE (PDB ID 3IC1)
(Figure 1A, B, & C) [16]. Both structures overlay closely with rmsd
for Ca atoms of 0.65 A˚ over 254 residues. Two zinc atoms were
found in the active site and reside in the same position as in
dimeric structure of WT-HiDapE separated by 3.40 A˚. Superim-
position of the active site regions shows nearly identical
conformations of main chain and side chains with rmsd as low
as 0.15 A˚ for the metal ions and side chains of residues involved in
their coordination (Figure 1C). Therefore the structure of the
catalytic core of the enzyme is extremely well preserved in the
truncated enzymes. Larger differences within the active site area
are observed in two regions containing solvent exposed loops.
Region I (residues 176–187) has been engineered to replace what
was originally the connector/hinge region formed by two loops
linking the catalytic domain with the dimerizaton domain
(Figure 1C, Region I). This region is highly flexible and is
disordered in the crystal structure of HiDapET (no electron density
observed for residues 182–187). Region II (residues 209–224),
which corresponds to a loop overhanging the active site metal ions
(loop V, vide infra) adopts a different conformation in comparison
to that observed in the HiDapE structure (rmsd of 1.5 A˚ between
the structures). Two residues within loop V (Gly21 and Gly212)
are disordered in the structure of HiDapET (Figure 1C).
Structure of the catalytic domain of VcDapET
The monomeric state of VcDapET was confirmed by SEC (the
estimated MW of 28.7 kDa) and DLS measurements (the
estimated average MW of 23.2 kDa) (Table 2). Two VcDapET
structures were determined, the apo- and the dinuclear Zn(II)-
loaded form. The final models for both apo- and Zn(II)-loaded
VcDapET included two molecules of the catalytic domain in the
asymmetric unit. The two V. cholerae structures are virtually
identical and superimpose with the average rmsd of 0.25 A˚ for 265
equivalent Ca atoms suggesting that binding of Zn(II) does not
induce any major structural changes (Figure 2A). The structures of
the catalytic domains of both apo- and Zn(II)-loaded VcDapET
closely resemble that of the catalytic domain of active WT-
HiDapE (PDB ID 3IC1). Superimposition of the Zn(II)-loaded
VcDapET structure and Zn(II)-loaded HiDapET shows that they
also overlay closely with (the average rmsd of 0.81 A˚ for 248
equivalent Ca atoms, Z-score 17, sequence similarity 59%)
(Figure 2B). Likewise, the structure of Zn(II)-loaded VcDapET is
almost identical to that of the catalytic domain of the full-length
HiDapE with rmsd of 1.15 A˚. The similarity between these
structures is especially apparent within the active site region of
Zn(II)-loaded VcDapET as the active site structure differs by only
,0.45 A˚ rmsd with the active site of HiDapET and ,0.4 A˚ with
the WT-HiDapE (Figure 2A and B). Similarly to HiDapET, the
most flexible regions of the protein are Region I and Region II.
Region I corresponds to the engineered loop (the connector) where
the deleted dimerization domain is replaced with two glycines.
Region II (residues 210–224) forms a loop overhanging the active
site metal ions, which includes residues 211–213 that form part of
loop V (vide infra) (Figure 2B).
The active sites of HiDapET and VcDapET
The sequence identity of HiDapE and VcDapE is high (59%),
and the residues comprising the active site are fully conserved. The
active site of DapE is located in the center of the catalytic domain
above the centrally located parallel strands of the b-sheet and is
formed by six loops [loop I (H. influenzae notation, residues 68–75),
loop II (residues 95–102), loop III (residues 132–141), loop IV
(residues 162–174), loop V (residues 322–328 in HiDapE) and loop
VI (residues 341–355)] (Figure 1B). With the exception of loop V
that does not interact with the zinc ions, the remaining loops
contribute the conserved residues that coordinate the metal ions
(Figures 1B, 1C & 2B). Interestingly, loops I–IV and VI are in
virtually identical orientations in both VcDapET and HiDapET
and overlay very well with the corresponding loops in WT-
HiDapE. A change is observed in loop V, which in VcDapET
adopts a conformation that is significantly different from the one
observed for WT-HiDapE (Figures 1A & 2B) (in HiDapET this
loop is disordered). The active site of Zn(II)-loaded VcDapET
contains a (m-oxygen)(m-carboxylato)dizinc(II) core with one
terminal carboxylate and one histidine residue at each metal site
([ZnZn(VcDapET)]), that is identical to the active site observed for
WT-HiDapE [16]. The main difference between the active sites in
the two Zn(II)-loaded H. influenzae structures (WT-HiDapE and
HiDapET) and [ZnZn(VcDapET)] is the presence of additional
electron density in chain A, which is overlapping with the bridging
water/hydroxide molecule observed in chain B and WT-HiDapE.
The 2Fo-Fc and Fo-Fc electron density maps were quite clear and
indicate that a small molecule (most likely ethylene glycol or a
partially disordered glycerol molecule) (Figure 2C) displaces the
bridging water/hydroxide molecule in the [ZnZn(HiDapE)] and
[ZnZn(HiDapET)] structures. Both of these compounds were
present in the cryoprotectant solution. Based on the best fit, an
ethylene glycol molecule was modeled in the active site resulting in
a distorted tetrahedral coordination geometry for Zn1, which is
bound by the carboxylate oxygen atoms OD1 of D101 and OE1
of E164 as well as a nitrogen atom NE2 of H68. Zn2 adopts a
distorted trigonal bipyramidal geometry and is coordinated by the
bridging O2 oxygen atom from ethylene glycol, a nitrogen atom
NE2 of H239, two oxygen atoms, OD2 from D101 and OE2 from
E136, and the O1 oxygen atom of ethylene glycol (Figure 2D).
The Zn1-Zn2 distance is 3.39 A˚.
Molecular Modeling and Dynamics
MD calculations were performed for five proteins: VcDapET,
HiDapET, WT-VcDapE, WT-HiDapE and AAP. After equilibra-
tion, the rmsd values for the main-chain atoms of [ZnZn(VcDa-
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pET)] and [ZnZn(HiDapET)] were compared with the original X-
ray structures and only small changes were observed. Similarly,
small changes were seen after equilibration of VcDapE and
HiDapE as well as AAP, which is monomeric and contains a single
catalytic domain. Since only the two truncated proteins were
catalytically inactive, particular attention was given to how these
proteins differed from the other three. Figure 3 shows the results of
the 5 ns molecular dynamics simulations of the truncated proteins
and comparisons to their crystallographic temperature factors. All
of the MOLMOL plots used only the first 5 ns of data so that they
are directly comparable. The thickness of the line indicates the
flexibility of the structure at a given point during the simulation
(Figure 3A and B). The portions of [ZnZn(VcDapET)] that have
the greatest flexibility include the created dimerization domain
loop and the active site loop V (Figure 2). This is consistent with
the crystallographic atomic displacement parameters indicating
that the most dynamic portions includes residues 177–187 and
loop V (Figure 3C). Compared to the other three structures, the
two truncated proteins have greater flexibility in both of these
loops (Figure 3) than the wild-type proteins (Figure 4).
Mutation of the Loop V Residue T325
Since both X-ray crystallographic and MD simulations
suggested that loop V flexibility increases in VcDapET and
HiDapET, it was hypothesized that this loop plays an important
role in constituting the active site and possibly substrate
recognition and/or transition-state stabilization. Since T325 in
HiDapE is centrally positioned in loop V directly above the
dinuclear Zn(II) site (Figure 5), the site-directed mutants T325A,
T325S and T325C were prepared and purified. The kcat value
obtained for T325A using L,L-SDAP as the substrate was
460.5 s21 with a corresponding Km value of 2.160.2 mM while
the kcat value obtained for T325S was 2.960.3 s
21 with a Km value
of 3.060.3 mM. Interestingly, when T325 was replaced by
cysteine, no enzyme activity was observed under standard assay
conditions. CD spectra obtained for each mutant enzyme plus
WT-HiDapE, indicate no significant structural change in the
mutant enzymes. These data confirm that T325 and hence the
position of loop V is important for the active site organization and
catalysis.
Discussion
Sequence comparison of all M20 classified metallopeptidases
and the M28 family of dinuclear Zn(II)-dependent metallopro-
teases, which include AAP and CPG2 [17,18,35], shows that all of
the metal coordinating residues are strictly conserved
[10,23,36,37]. Unlike AAP, which is monomeric, DapE enzymes
form dimers where each subunit consists of two functional
domains: a larger catalytic domain, which houses the active site
and a dimerization domain that forms the dimer interface
(Figure 1A). The location and architecture of the catalytic domain
and the dinuclear Zn(II) active site in dimeric WT-HiDapE is
nearly identical to the catalytic domain and the active site of
monomeric AAP [17,38]. The catalytic domain of HiDapE is
composed of residues 1–179 and 293–376 where the core of the
catalytic domain contains an eight-stranded twisted b-sheet that is
sandwiched between seven a-helices. The active site is located in
the center of the catalytic domain above the centrally located
parallel strands of the b-sheet and is constituted by six loops. With
the exception of loop V that encloses the active site from the top
and does not interact with the zinc ions, the remaining loops
contribute the conserved residues that coordinate the metal ions
(Figure 1B). The dimerization domain of HiDapE consists of a
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114-residue insertion into the catalytic domain and is connected to
the catalytic domain by two short loops. Since the dimerization
domain is located away from the active site and has only limited
interaction with the catalytic domain via loop V, it is unclear
whether this domain plays any role in catalysis. Such a role for the
dimerization domain would require a major conformational
change to bring the dimerization domain residues into the active
site. While this is possible, the time frame would be well beyond
the range of atomistic MD simulations.
To address this issue, we engineered DapE enzymes with no
dimerization domains (HiDapET, VcDapET). The nested trunca-
tion was designed based on the WT-HiDapE crystal structures
with the goal of preserving the catalytic domain structure and keep
its active site intact. The HiDapET and VcDapET constructs
expressed well, were purified, the monomeric states of both
proteins in solution was confirmed, and their catalytic activities
examined. Surprisingly, we could not detect enzyme activity for
either truncated variant towards L,L-SDAP, whereas WT-
HiDapE exhibited kcat and Km values in good agreement with
those previously reported [23]. For comparison purposes, the kcat
and Km were also determined for WT-VcDapE and found to be
similar to the values reported for WT-HiDapE. These data suggest
that the deletion mutants have significantly diminished catalytic
activity or are fully catalytically inactive.
To understand the structural basis of the observed absence of
catalytic activity of both engineered enzymes, we determined the
crystal structures of the truncated forms of HiDapET ([ZnZn(Hi-
DapET)]) and VcDapET ([ZnZn(VcDapET)]) along with the apo-
form of VcDapET. These structures reveal that the catalytic
domain is indeed unchanged, including complete structural
preservation of the catalytic site and metal core. It is clear that
deletion of the dimerization domain does not compromise the
catalytic domain structure. The structure of [ZnZn(HiDapET)] is
virtually identical to the catalytic domain the WT-HiDapE with an
rmsd of 0.8 A˚ for 248 equivalent Ca atoms. Interestingly, the
newly determined structure of [ZnZn(VcDapET)] also shows high
similarity to the catalytic domain of WT-HiDapE with an rmsd of
1.15 A˚ for 246 equivalent Ca atoms. Since the structures of
VcDapET were determined in both the apo- and dinuclear Zn(II)-
loaded forms, it is evident that removal of either the dimerization
domain or the metal cations does not alter the overall structure of
the catalytic domain.
The dinuclear Zn(II) active sites in both HiDapET and
VcDapET are nearly identical to each other with Zn-Zn distances
of ,3.40 A˚. These Zn-Zn distances are comparable to those
observed for AAP (3.45 A˚), HiDapE (3.33 A˚) and carboxypepti-
dase G2 (CPG2) (3.25 A˚) [18,37]. Similar to AAP, HiDapE, and
CPG2 one of the Zn(II) ions in [ZnZn(VcDapET)] adopts a
distorted tetrahedral geometry while the second Zn(II) ion is
trigonal bipyramidal. Identical to CPG2, HiDapE, and AAP each
zinc ion is coordinated by one imidazole group (H68 for Zn1 and
H239 for Zn2) and the oxygen atoms of E164 for Zn1 and E136
Figure 1. X-ray Crystal Structures of WT-HiDapE and HiDapET. A) Dimer architecture based on the structure of WT-HiDapE. B) Close-up view
of the catalytic domain of WT-HiDapE. Ribbon diagram showing the active site formed by six loops (LI–LVI); five of them coordinate the Zn ions (LI–IV
& VI). C) Superimposition of the structure of WT-HiDapE (black) over HiDapET (magenta). Active site Zn(II) ions are shown as black and magenta
spheres for WT-HiDapE and HiDapET, respectively. Regions where differences are most prominent are labeled Region I (yellow) and Region II (orange).
Yellow and magenta circles highlight two disordered loop regions in the HiDapET structure. The red dots marked disordered loop that contains
conserved His residue.
doi:10.1371/journal.pone.0093593.g001
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for Zn2. Both zinc ions are bridged by D101 and a single oxygen
atom of ethylene glycol (in the molecule one, chain A) and a water
molecule (in the second molecule, chain B). Overall the
[ZnZn(VcDapET)] structure confirms that the metal ions form a
(m-oxygen)(m-carboxylato)dizinc(II) core similar to HiDapE, AAP,
and CPG2 [39], and indicates that the active site catalytic unit is
intact in the truncated forms of DapE. Therefore, the lack of the
catalytic activity is puzzling and clearly is not due to missing a key
element in the HiDapET and VcDapET dinuclear active site.
Comparison of the [ZnZn(HiDapET)] and [ZnZn(VcDapET)]
structures with that of WT-HiDapE (PDB ID 3IC1) (Figure 1C &
2B) reveals that one of the six loops comprising the catalytic core,
loop V (residues 210–214 in HiDapET and 211–215 in VcDapET,
and corresponding to 321–325 in HiDapE) exists in a significantly
different orientation than that observed in WT-HiDapE. Interest-
ingly, this loop is also partially disordered in the structure of
HiDapET, while in VcDapET structures its conformational
flexibility is signified by the double conformation of the main
chain Gly 213 (peptide flip). In previous studies, we proposed that
this loop might be involved in the positioning and stabilization of
the substrate in the active site, therefore the loop conformation
might be critical for proper substrate binding and positioning as
well as stabilization of the transition-state during the catalytic cycle
[16]. This is supported by two loop V mutations (T325A, T325S)
that show similar Km to WT but significantly reduced (25–50
times) kcat values. These data suggest that the substrate is bound
with similar specificity, but is not effectively presented to the
catalytic core for successful catalysis. Since the same region is
affected in both HiDapET and VcDapET, where loop V is out of
place compared to the WT-HiDapE, we hypothesized that this
region is important for catalysis. Both of the observed orientations
and the greater flexibility of this loop (Figures 2B & 3) seem to be
due to the lack of interactions with specific portions of the
dimerization domain. Several interactions may be particularly
critical. First, loop V in WT-HiDapE is partially held in position
by the anti-parallel beta strands (b7 and b12) and interactions with
a loop connecting b7 with the dimerization domain. These
contacts are missing in the truncated protein as portions of strands
b7 and b12 have been transformed into a deletion-derived loop
and a helix (Figure 2B). Loop V in WT-HiDapE is also held in
place by the loop from the dimerization domain (residues 223 to
228) (Figure 6). These contacts are also missing in the truncated
protein.
Interestingly, the structure of WT-HiDapE contains a sulfate ion
located at the interface of the catalytic and dimerization domains
and positioned very closely to loop V. The sulfate binding may
have biological relevance and might indicate a region where the
L,L-diaminopimelic acid moiety of the substrates binds. Several
residues from both domains interact with this sulfate ion. These
include Arg178 (NE), Arg179 (NH), and Gly324 (amide NH;
residue in loop V) from the catalytic domain and Arg258 (NH)
from the dimerization domain (corresponding to Arg179, Arg180,
Figure 2. X-ray Crystal Structures of VcDapET. A) Superimposition of apo-VcDapET (blue) over [ZnZn(VcDapET)] (cyan), showing the identical
nature of the catalytic domains. Zinc atoms for VcDapET are shown as black spheres. B) Comparison of [ZnZn(VcDapET)] (cyan) and [ZnZn(HiDapET)]
(magenta). Regions I (yellow) and II (orange) identify the areas where the most significant differences between the two structures exist. Six loops (LI–
LVI) forming the active site are labeled. Zinc atoms for VcDapET are shown as black spheres while the residues coordinating the metal ions are shown
as lines. C) Close-up view of the active site environment of the [ZnZn(VcDapET)] with the 2Fo2Fc electron density map (with the Zn ions and ethylene
glycol molecules omitted from the calculation). D) Close-up view of residues from loops I–IV and VI interacting with the Zn(II) ions in the structure of
[ZnZn(VcDapET)]. E) The 2Fo2Fc (blue, 1 s) and Fo2Fc electron-density maps (red and green at 23s and 3s) of the LV loop region in the apo-
VcDapET.
doi:10.1371/journal.pone.0093593.g002
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Gly325 and Arg259 in WT-VcDapE) (Figure 6). This interaction is
completely absent in the structure of the [ZnZn(VcDapET)] and
residues Arg178 and Arg179 are part of the deletion-derived
distorted a helix, whereas Gly214 (corresponding to Gly324 in
WT-HiDapE) located within loop V does not form any observable
interactions (Figure 6).
Another indication that the specific orientation of loop V may
be crucial for catalysis comes from MD simulations of the
truncated DapE structures compared to WT-DapE and AAP
(Figure 4). Consistent with the large crystallographic temperature
factors, the greatest flexibility in the truncated forms of DapE are
observed in the engineered loop created to replace the deleted
dimerization domain and loop V, which directly overhangs the
dinuclear active site (Figure 3C and D). For comparison, loop V in
the apo-structure of NmDapE (PDB entry 1vgy) is well ordered and
positioned such that it allows two arginine residues (Arg179,
Arg259 corresponding to the pairs Arg178/Arg258 and Arg179/
Arg259 in HiDapE and VcDapE, respectively) to closely approach
the active site. It is highly likely that these Arg residues, which are
semi-conserved (Arg178) or conserved (Arg259) in DapEs, might
interact with the carboxylate moieties of the substrate. Conserved
Arg residues were shown to be essential for substrate binding in
human aminoacylase-1 (Acy1) (40). Interestingly in AAP, which
exists as a monomeric protein of only the single catalytic domain,
there is a loop residing directly over the dinuclear zinc active site
that corresponds to loop V in DapE. This loop is very rigid, unlike
loop V in DapE, and appears to be held in place by an internal
disulfide bridge formed between C223 and C227 (Figure 6). A
decrease in dynamic flexibility due to changes in quaternary
structure has been suggested for other proteins [40].
Apart from loop V, an additional loop might play an important
role in catalysis. Studies on Acy1, another dimeric member of the
Figure 3. Diagrams Showing Regions of Flexibility in Truncated DapE Proteins. A) MOLMOL diagram of [ZnZn(VcDapET)] molecular
dynamics. B) MOLMOL diagram of [ZnZn(HiDapET)] molecular dynamics (the thickness of the line is proportional to the variation of the protein
structure during the simulation). The crystallographic temperature factors indicating that the most dynamic (in red) and the most rigid (in blue) parts
of the protein: C) [ZnZn(VcDapET)]. D) [ZnZn(HiDapET)].
doi:10.1371/journal.pone.0093593.g003
Figure 4. Molecular Dynamic Simulation Showing Regions of Flexibility in Catalytic Domain. A) [ZnZn(VcDapE)]. B) [ZnZn(HiDapE)]. C)
AAP. The thickness of the line is proportional to the variation of the protein structure during the simulation. AS indicates the active site area, LVeq.
equivalent of the LV loop in HiDapE).
doi:10.1371/journal.pone.0093593.g004
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M20 family, showed that the dimerization domain contributes to
the active site through interactions with the substrate (40). Lindner
et al. (40) showed that the alanine mutant of His206, which is
located at the center of the loop, rendered the enzyme nearly
inactive. An equivalent histidine residue is conserved in DapE
enzymes (H194 in HiDapE and H195 in VcDapE), but it is
disordered in the WT-HiDapE structure (17). Modeling of this
disordered loop region (Figure 1A) positions H194 roughly ,13 A˚
from the active site core, which is likely too far to interact with the
substrate. However, it is possible that this loop can rearrange upon
substrate binding as was reported for Acy1 and Sapep [40,41].
Evidence for such loop movement can be gleaned from the
structure of apo-NmDapE where this loop is positioned within 8 A˚
of the active site. These data suggest that this His residue may also
play an important role in substrate recognition and binding by
DapE enzymes. This hypothesis is consistent with the wild-type
DapE structural design as the presence of the inter-domain clefts
and connectors would allow for significant movement of this
domain. Confirmation of the role of His194 in substrate
recognition and binding must await a structure of DapE in
complex with a substrate analog.
Conclusions
Removal of the dimerization domain in DapE enzymes renders
the enzyme inactive, even though the resulting truncated proteins
have structures of the catalytic domain that are remarkably similar
to WT-DapE and AAP. In fact, the dinculear Zn(II) site in the
truncated DapE enzymes is nearly identical to those observed for
AAP and WT-HiDapE. Therefore, one would expect that the
active site should be capable of catalyzing a hydrolytic reaction
and yet no activity is detected. This suggests that positioning of the
substrate in the active site is critical for the catalytic reaction to
occur. Analysis of the structures HiDapET and VcDapET reveals
that loop V is much more flexible in the truncated enzymes than
WT-DapE due to the lack of interactions provided by the
dimerization domain. These data suggest that the dimerization
domain functions to restrict the conformational freedom of the
loop V region and may contribute residues to the active site
environment (H194, R179, R258, T325) that are important for
substrate recognition, and binding. Designing small molecules
inhibitors that interact with this active site loop V region as well as
the dinuclear metal center, or disrupting dimer formation may
lead to more potent DapE inhibitors that can function as
antibacterial agents.
Figure 5. The Active Site of WT-HiDapE Showing Loop V. T325
resides on loop V directly over the dinuclear active site.
doi:10.1371/journal.pone.0093593.g005
Figure 6. The Role of the Dimerization Domain in the Stabilization of Loop V in WT-HiDapE. A) Superimposition of the WT-HiDapE (gray)
and VcDapET (cyan) structures is shown. Loop V of WT-HiDapE and VcDapET is labeled as HiLV and VcLV, respectively. WT-HiDapE residues interacting
with the sulfate ion (stick model) are shown as gray lines. Corresponding residues in VcDapET (except for R258 that is absent in the deletion mutant)
are shown as yellow (R179 and R180) and orange (G214) lines. B) Specific orientation of the active site loop V in VcDapET and the corresponding loop
in AAP. Overlay of the VcDapET (cyan) and AAP (purple) structures is shown. The AAP loop and VcDapET loop V are labeled as ApLV and VcLV,
respectively. Stabilization of loop V in AAP by a disulfide bridge is indicated where Cys223 and Cys227 of AAP and the residues involved in zinc-
binding in VcDapET are shown as sticks. Zinc ions of VcDapET are shown as black spheres. Zinc-bound ethylene glycol was omitted for clarity.
doi:10.1371/journal.pone.0093593.g006
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Supporting Information
File S1 A. Analysis of the oligomeric state by size exclusion
chromatograpy. Chromatogram showing elution of three DapE
proteins (WT-HiDapE (blue), HiDapET (red), VcDapET(green))
from the calibrated column. The inset shows the calibration curve
obtained by plotting Kav versus logMW forthe following standard
proteins: Aprotinin (6.5 kDa, I), ribonuclease A (13.7 kDa, II),
carbonic anhydrase (29 kDa, III) ovalbumin (43 kDa, IV),
conalbumin (75 kDa,V), aldolase (158 kDa, VI), ferritin
(440 kDa, VII), and thyroglobulin (669 kDa, VIII). B. The
secondary structure of WT DapE and T325 mutants were
measured using OlisDSM 20 circular dichrometer. Data was
collected at room temperature with constant nitrogenflow every
1 nm, in the wavelength range of 190–260 nm. All samples were
measured in acylindrical quartz cuvette with a 1 mm pathlength in
10 mM phosphate buffer pH 7.0. Threerepetitive scans were
averaged, smoothed and background-subtracted for each mea-
surement. Millidegree values obtained were converted to molar
ellipticity (deg?cm2?dmol-1) by using the equation: Molar
ellipticity = moM/106L6C, where mo is millidegrees, M is
molecular weight (g/mol), L is path length of cuvette (cm) and C
is concentration (g/L).
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